NCT06912191

Brief Summary

Experiment1: Using a brain EEG-TMS combined system, researchers aim to investigate the impact of the rostral anterior cingulate cortexr (rACC)-engaging cognitive task (RECT) combined single-pulse TMS magnetic stimulation on theta neural oscillations in the medial frontal lobe. The study will be divided into 4 groups: the first group will receive left cerebellar single-pulse TMS stimulation combined with the RECT task, the second group will receive right cerebellar single-pulse TMS stimulation combined with the RECT task, the third group will receive midline cerebellar single-pulse TMS stimulation combined with the RECT task, and the fourth group will receive sham cerebellar single-pulse TMS stimulation combined with the RECT task. Divide the participants into groups of 15 people each, following a 1:1:1:1 ratio. Based on the above testing, the stimulus method that results in the most significant change in the midline of the frontal lobe will be identified. Experiment 2: Based on the research from Experiment 1, the most significant approach affecting theta neural oscillations in the medial frontal gyrus will be identified. This stimulation protocol will be combined with left dorsolateral prefrontal cortex iTBS stimulation in Experiment 2. The research aim of Experiment 2 is to investigate the most effective stimulation method for enhancing midline theta neural oscillations in the frontal lobe, in combination with left dorsolateral prefrontal cortex iTBS, for the treatment of post-stroke depression patients. This study will include 40 post-stroke depressed patients, and each participant must meet the inclusion criteria. The first group of participants, consisting of 20 individuals, will receive the optimal combination intervention. The second group of participants will only receive iTBS stimulation, without any additional intervention strategies used in Experiment 1. Patients will undergo Hamilton Depression Scale assessment and resting state and task state EEG collection at baseline, one week after intervention, and two weeks after intervention.The primary outcome will be the Hamilton Depression Scale, with EEG-related data being analyzed as a secondary outcome. Task-oriented EEG detection will include both facial expression recognition paradigm and oddball experiment paradigm. Reaction time, accuracy, and completion status will be recorded simultaneously in the experiment. The experiment will record patients' tolerance and any adverse events that occur.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
13mo left

Started Mar 2025

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Mar 2025May 2027

First Submitted

Initial submission to the registry

March 29, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

March 30, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 4, 2025

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2027

Last Updated

April 4, 2025

Status Verified

March 1, 2025

Enrollment Period

1.9 years

First QC Date

March 29, 2025

Last Update Submit

March 29, 2025

Conditions

Keywords

EEGERP

Outcome Measures

Primary Outcomes (2)

  • Montgomery-Asberg Depression Rating Scale,MADRS

    This scale will be the primary outcome measure for Experiment 2. Montgomery-Asberg Depression Rating Scale,MADRS: Extreme depression: MADRS \>35; Major depression: MADRS \>30; Moderate depression: MADRS \>22; Mild depression: MADRS \>12; Remission stage: MADRS \<12.

    Day1

  • Electroencephalogram

    EEG will be the main outcome measures for Experiment 1 and Experiment 2. EEG power in the delta, theta, alpha, beta band: the power spectral density (PSD) in unit\^2/Hz Functional connectivity---Phase locking value (PLV): The value of PLV ranges from 0 to 1 Event related potentials in amplitude/μV

    Day 1

Secondary Outcomes (7)

  • Mini-mental state examination,MMSE

    Day 1

  • Montreal Cognitive Assessment, MoCA

    Day 1

  • Hamilton Depression Scale,HAMD

    Day 1

  • Hamilton Anxiety Scale,HAMA

    Day 1

  • Quick Inventory of Depressive Symptomatology Self-Report, QIDS-SR16

    Day 1

  • +2 more secondary outcomes

Study Arms (7)

LC TMS combined with the RECT task (Experiment1)

EXPERIMENTAL

Left cerebellar single-pulse TMS stimulation combined with the RECT task

Other: Left cerebellar TMS stimulation combined with the RECT task

RC TMS combined with the RECT task (Experiment1)

EXPERIMENTAL

Right cerebellar single-pulse TMS stimulation combined with the RECT task

Other: Right cerebellar TMS stimulation combined with the RECT task

MC TMS combined with the RECT task (Experiment1)

EXPERIMENTAL

Midline cerebellar single-pulse TMS stimulation combined with the RECT task

Other: Midline cerebellar TMS stimulation combined with the RECT task

Sham cerebellar single-pulse TMS stimulation combined with the RECT task (Experiment1)

SHAM COMPARATOR

Sham cerebellar single-pulse TMS stimulation combined with the RECT task, The TMS coil was placed at the cerebellar site but tilted 90° to prevent effective magnetic field penetration.

Other: Sham cerebellar TMS stimulation combined with the RECT task

Combined Stimulus Intervention group (Experiment 2)

EXPERIMENTAL

Combined iTBS stimulation of the dorsolateral prefrontal cortex and TMS of the cerebellum with the RECT task intervention group

Other: The best stimulation protocol combined with left dorsolateral prefrontal cortex iTBS

iTBS treatment group(Experiment 2)

EXPERIMENTAL

The group of participants will receive left dorsolateral prefrontal cortex iTBS stimulation, as well as sham cerebellar TMS stimulation and sham RECT task.

Other: Left dorsolateral prefrontal cortex iTBS stimulation, as well as sham TMS stimulation and sham RECT task.

Traditional treatment group(Experiment 2)

SHAM COMPARATOR

The group of participants will receive sham left dorsolateral prefrontal cortex iTBS stimulation, sham cerebellar TMS stimulation, and sham RECT task.

Other: Sham left dorsolateral prefrontal cortex iTBS stimulation, sham cerebellar TMS stimulation, and sham RECT task.

Interventions

The first group will receive left cerebellar single-pulse TMS stimulation combined with the RECT task. RECT refers to rostral anterior cingulate cortexr (rACC)-engaging cognitive task. The theoretical basis of this task is that when subjects are in a state of focused attention, the power of theta neural oscillations in the midline of their frontal lobe will increase. By considering the features of post-stroke depression, this study combines the emotional recognition task with the RECT task. During each trial, individuals will view 4 faces consecutively, each displaying a different expression, and they will be required to memorize the sequence of expressions. Emoticons consist of joy, sorrow, and rage. After displaying four facial expressions, a brief text flowchart will appear. Participants need to check if the sequence reflected in the flowchart matches the order in which the four facial expressions appeared. If they match, click the left mouse button; if they do not match, click the

Also known as: RECT task, TMS
LC TMS combined with the RECT task (Experiment1)

Right cerebellar single-pulse TMS stimulation combined with the RECT task

Also known as: RECT task, TMS
RC TMS combined with the RECT task (Experiment1)

Midline cerebellar single-pulse TMS stimulation combined with the RECT task

Also known as: RECT task, TMS
MC TMS combined with the RECT task (Experiment1)

Sham cerebellar single-pulse TMS stimulation combined with the RECT task, The TMS coil was placed at the cerebellar site but tilted 90° to prevent effective magnetic field penetration.

Also known as: RECT task
Sham cerebellar single-pulse TMS stimulation combined with the RECT task (Experiment1)

The optimal stimulation protocol determined in Experiment 1 combined with stimulation of the left dorsolateral prefrontal cortex.

Also known as: left dorsolateral prefrontal cortex iTBS, RECT task, TMS
Combined Stimulus Intervention group (Experiment 2)

Subjects in the group underwent left dorsolateral prefrontal cortex iTBS stimulation, in addition to receiving sham TMS stimulation and participating in a sham RECT task. The sham RECT task involves having participants watch a continuous scroll of faces without needing to react.

Also known as: left dorsolateral prefrontal cortex iTBS
iTBS treatment group(Experiment 2)

The participants in this group received sham left dorsolateral prefrontal cortex iTBS stimulation, sham cerebellar TMS stimulation, and sham RECT task.

Traditional treatment group(Experiment 2)

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Onset of stroke \<6 months ago, or \>6 months since the last stroke event;
  • Age \>=18 years and \<85 years (as the probability of Vascular Cognitive Impairment increases above 85);
  • Patients with damage in the middle cerebral artery territory;
  • NIHSS \>4 and \<26;
  • mRS score \>=2;
  • Completion of CT or MRI;
  • No neurological or psychiatric disorders; no impairment of consciousness; able to comply with relevant treatments; no severe cognitive dysfunction (MMSE \>=15);
  • All participants are right-handed; Sign the informed consent form.

You may not qualify if:

  • History of epilepsy or psychiatric disorders (including depression, anxiety, or schizophrenia);
  • Severe comorbidities;
  • History of medication use: benzodiazepines, baclofen, antidepressants;
  • Non-compliance with the treatment plan;
  • Acute-phase cerebral hemorrhage, acute infectious diseases;
  • Severe suicidal tendencies in individuals with depression;
  • Individuals suffering from severe headaches, high blood pressure, malignant tumors, open wounds, vascular embolism, leukopenia, etc.;
  • Severe alcohol abuse;
  • History of cranial surgery, individuals with metal implants in the brain;
  • Individuals with an implanted cardiac pacemaker;
  • NIHSS \>26, MMSE \<15;
  • Any disease likely to prevent the patient from surviving more than one month;
  • Pregnant individuals.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Department of Rehabilitation Medicine, the Second Affiliated Hospital of Kunming Medical University

Study Record Dates

First Submitted

March 29, 2025

First Posted

April 4, 2025

Study Start

March 30, 2025

Primary Completion (Estimated)

February 28, 2027

Study Completion (Estimated)

May 30, 2027

Last Updated

April 4, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share